期刊
DRUG METABOLISM AND DISPOSITION
卷 38, 期 6, 页码 988-994出版社
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/dmd.109.031831
关键词
-
资金
- National Institutes of Health National Center for Research Resources [P20-RR021940, 2P20-RR016475]
- National Institutes of Health National Institute of General Medical Sciences [R01-GM087376]
- University of Kansas
- University of Kansas Medical Center
- Kansas University School of Medicine
- National Institutes of Health National Institute of Child Health and Human Development [HD02528]
HepaRG cells, derived from a female hepatocarcinoma patient, are capable of differentiating into biliary epithelial cells and hepatocytes. More importantly, differentiated HepaRG cells are able to maintain activities of many xenobiotic-metabolizing enzymes, and expression of the metabolizing enzyme genes can be induced by xenobiotics. The ability of these cells to express and induce xenobiotic-metabolizing enzymes is in stark contrast to the frequently used HepG2 cells. The previous studies have mainly focused on a set of selected genes; therefore, it is of significant interest to know the extent of similarity of gene expression at whole genome levels in HepaRG cells and HepG2 cells compared with primary human hepatocytes and human liver tissues. To accomplish this objective, we used Affymetrix (Santa Clara, CA) U133 Plus 2.0 arrays to characterize the whole genome gene expression profiles in triplicate
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据